Accessibility Menu
Imricor Medical Systems logo

Imricor Medical Systems(ASX) IMR

Market CapA$724.66MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)+39%
5 Year+46%
1 Year+54%
1 Month+23%
A$2.05
+5.13%
+0.10Today
Imricor Medical Systems last closing stock price
MetricPriceDate
Last closeAUD 2.052026-08-13
Imricor Medical Systems stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+8.18%AUD 1.902026-08-06
1 month+22.75%AUD 1.672026-07-14
3 month+11.11%AUD 1.852026-05-15
Year to date+33.99%AUD 1.532025-12-31
1 year+53.56%AUD 1.342025-08-13
3 year+225.4%AUD 0.632023-08-14
5 year+45.91%AUD 1.412021-08-13
Since inception+38.87%AUD 1.402019-08-30

Imricor Medical Systems Financials at a Glance

Market Cap

A$724.66MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.16M

Net Income (TTM)

-$48.66M

EPS (TTM)

-A$0.13

P/E Ratio

-16.05

Dividend

A$0.00

Beta (Volatility)

0.03 (Low)

Price

A$2.05

Volume

521,816

Open

A$1.97

Previous Close

A$2.05

Daily Range

A$1.95 - A$2.05

52-Week Range

A$1.28 - A$2.25

Estimated Earnings Date

Sep 1, 2026

IMR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Imricor Medical Systems

Imricor Medical Systems, Inc. is a medical device company specializing in MRI-compatible products for cardiac catheter ablation procedures. The company designs, manufactures, and distributes innovative solutions aimed at improving patient outcomes in the United States, Europe, and the Middle East.

Products and Services
  • Vision-MR Ablation Catheter 2.0 for cardiac ablation
  • NorthStar mapping system for high-resolution MRI imaging
  • Advantage-MR EP Recorder / Stimulator for electrophysiology
Growth Outlook
  • Expanding market for MRI-compatible medical devices supports growth potential
  • Increased focus on minimally invasive procedures drives demand for innovative solutions
  • Strategic partnerships may enhance market reach and product offerings
Financial Highlights
  • Recent quarterly revenue of 97,186 reflects ongoing operational challenges
  • Trailing twelve months (TTM) net income margin stands at -96.98%
  • Current ratio of 2.47 indicates strong short-term liquidity position
Imricor Medical Systems, Inc. operates in the specialized medical device sector, focusing on cardiac procedures that leverage MRI technology. The company's flagship products, including the Vision-MR Ablation Catheter and NorthStar mapping system, are designed to enhance the precision and safety of cardiac interventions. Despite facing financial challenges, the company is positioned in a growing market that increasingly values innovative, minimally invasive solutions. The current liquidity position suggests that Imricor is capable of navigating its operational hurdles while exploring avenues for growth and expansion.
AI Generated • Jul 22, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Steven Wedan

Website

www.imricor.com

Headquarters

Burnsville, MN 55337, US

IMR Financials

Key Financial Metrics (TTM)

Gross Margin

-895.69%

Operating Margin

-8919.87%

Net Income Margin

-9697.97%

Return on Equity

-109.63%

Return on Capital

-62.90%

Return on Assets

-41.43%

Earnings Yield

-6.23%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$724.66MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

353.49M

Volume

521.82K

Avg. Volume

382.25K

Financials (TTM)

Gross Profit

-$2.68M

Operating Income

-$33.75M

EBITDA

-$32.27M

Operating Cash Flow

-$29.97M

Capital Expenditure

-$389.62K

Free Cash Flow

-$30.36M

Cash & ST Invst.

$40.81M

Total Debt

$25.97M

Imricor Medical Systems Performance Analysis

Imricor Medical Systems annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,177,11326.9%
20232023-12-31USD 927,387-21.2%
20242024-12-31USD 1,454,55756.8%
20252025-12-31USD 453,323-68.8%
Imricor Medical Systems sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-2.1%
Q42024-12-3135.3%
Q22025-06-30-82.2%
Q42025-12-31-1.3%
Imricor Medical Systems annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.17-14.5%
20232023-12-31USD -0.2226.7%
20242024-12-31USD -0.20-7.7%
20252025-12-31USD -0.13-36.7%
Imricor Medical Systems sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-3056.5%
Q42024-12-31-146.4%
Q22025-06-3075.0%
Q42025-12-31-73.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$97.19K

-76.7%

Gross Profit

-$1.44M

-287.0%

Gross Margin

-14.87%

N/A

Market Cap

A$724.66MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$9.29M

N/A

Employees

78

N/A

Net Income

-$12.40M

+7.5%

EBITDA

-$11.34M

-53.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$40.81M

+4807.6%

Total Debt

$25.97M

+149.2%

Accounts Receivable

$241.03K

-38.6%

Inventory

$1.10M

-34.8%

Long Term Debt

$13.90M

+42.5%

Short Term Debt

$12.06M

+1706.0%

Return on Assets

-41.43%

N/A

Return on Invested Capital

-61.43%

N/A

Free Cash Flow

-$10.03M

-48.0%

Operating Cash Flow

-$9.84M

-45.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AYA.AXArtrya Limited
A$4.69-2.29%
AFP.AXAFT Pharmaceuticals Limited
A$3.87+0.00%
PSQ.AXPacific Smiles Group Limited
A$2.18+0.00%
AVH.AXAVITA Medical, Inc.
A$2.28+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.62+0.07%
ONDSOndas
$8.93-0.09%
SMCISuper Micro Computer
$39.34+0.05%
SPCXSpace Exploration Technologies
$141.98-0.03%

Questions About IMR

What is the current price of Imricor Medical Systems?

Imricor Medical Systems is trading at A$2.05 per share.

What is the 52-week range for Imricor Medical Systems?

Over the past 52 weeks, Imricor Medical Systems has traded between A$1.28 and A$2.25.

How much debt does Imricor Medical Systems have?

As of the most recent reporting period, Imricor Medical Systems reported total debt of $49.11M.

How much cash does Imricor Medical Systems have on hand?

Imricor Medical Systems reported $67.06M in cash and cash equivalents in its most recent financial results.

What is Imricor Medical Systems’s dividend yield?

Imricor Medical Systems does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services